Chemoinformaics analysis of N-ACETYLDJENKOLIC-ACID
| Molecular Weight | 296.37 | nRot | 9 |
| Heavy Atom Molecular Weight | 280.242 | nRig | 3 |
| Exact Molecular Weight | 296.05 | nRing | 0 |
| Solubility: LogS | -1.814 | nHRing | 0 |
| Solubility: LogP | -2.711 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 37.7087 |
| nHD | 4 | BPOL | 23.5753 |
| QED | 0.328 |
| Synth | 3.458 |
| Natural Product Likeliness | 0.57 |
| NR-PPAR-gamma | 0.105 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.755 |
| HIA | 0.016 |
| CACO-2 | -6.79 |
| MDCK | 0.00000243 |
| BBB | 0.028 |
| PPB | 0.143745 |
| VDSS | 0.315 |
| FU | 0.796272 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.039 |
| CYP2c9-inh | 0.089 |
| CYP2c9-sub | 0.423 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.135 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.005 |
| CL | 2.21 |
| T12 | 0.882 |
| hERG | 0.009 |
| Ames | 0.009 |
| ROA | 0.011 |
| SkinSen | 0.253 |
| Carcinogencity | 0.397 |
| EI | 0.081 |
| Respiratory | 0.053 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.735908 |